Cystamine inhibits transglutaminase and caspase‐3 cleavage in glutamate‐exposed astroglial cells

Abstract

Although the precise role of transglutaminase in cell death is unknown, several findings demonstrate that tissue transglutaminase selectively accumulates in cells undergoing apoptosis both in vivo and in vitro. Calcium-dependent transglutaminase reactions are also implicated in several neurodegenerative diseases, including alterations in the release of excitatory amino acids. One prevalent theme in cell damage induced by excitotoxic stimuli in different regions of the CNS is that apoptosis may be executed by intracellular caspase proteases. Furthermore, the presence of functional ion channel-gated receptors in glial cells suggests that also astrocytes can be susceptible to glutamate's toxic effects. In this study, we demonstrated that prolonged exposure to glutamate (100 microM) of cultured astrocytes caused an increase in the expression of tissue transglutaminase (tTG). This effect was prevented by preincubation with GYKI 52466, an antagonist of AMPA/KA receptors. Glutamate exposure also promoted an increase in caspase-3 compared with control cultures. Confocal laser microscopy analysis demonstrated the presence of activated caspase-3 in the cytoplasm as well as in the nucleus. The inhibition of TG-catalyzed reactions by cystamine (1 mM) blocked the activation pathway of caspase-3, with an evident reduction of enzyme cleavage. These results suggest that glutamate increased both TG and caspase-3 in astroglial cells early in the excitotoxin-induced events.

Vanin-1 Is a Key Activator for Hepatic Gluconeogenesis

“…In the intestine, VNN1 promotes an inflammatory reaction and intestinal injury by decreasing the activity of g-glutamylcysteine synthetase and reducing the stores of reduced glutathione (15,16). Finally, because cysteamine is a transglutaminase inhibitor (34,35), VNN1 is implicated in the development of Huntington disease, which is characterized by the accumulation of highly cross-linked insoluble proteins. These proteins may be associated with an upregulation of transglutaminase (summarized in Fig.…”

Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes

“…Several non-mutually exclusive possibilities can be envisaged. Few putative enzymatic cysteamine targets have been characterised: they include transglutaminases [44], caspase 3 and protein kinase C (PKC)ɛ. STZ-induced cell death is dependent upon caspase 3 activation [33]. Interestingly, cystamine can partially inhibit caspase 3 in vitro [45] and this mechanism might contribute to its protective effect in Huntington's disease [26,27].…”

Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice

“…We speculate that regulation of GSH stores by Vanin-1 and regional accumulation of cysteamine could have effects on chondrogenic differentiation and on chondrocyte growth and mineralization in ank/ank mice that change over time. Physiological cysteamine and cystamine interconversion 26 also could indirectly regulate osteoblast differentiation and chondrocyte maturation in ank/ank mice, since cystamine inhibits caspase-3 [41][42][43] and transglutaminase activities, 41,44,45 respectively.…”